Cryoport, Inc. (CYRX)
NASDAQ: CYRX · Real-Time Price · USD
6.56
+0.04 (0.61%)
At close: Nov 22, 2024, 4:00 PM
6.64
+0.08 (1.22%)
After-hours: Nov 22, 2024, 4:01 PM EST

Company Description

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.

It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services.

In addition, the company offers MVE Biological Solutions’ Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions’ Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med.

Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services.

Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.

Cryoport, Inc.
Cryoport logo
Country United States
Founded 1999
Industry Integrated Freight & Logistics
Sector Industrials
Employees 1,030
CEO Jerrell Shelton

Contact Details

Address:
112 Westwood Place, Suite 350
Brentwood, Tennessee 37027
United States
Phone 949 470 2300
Website cryoportinc.com

Stock Details

Ticker Symbol CYRX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001124524
CUSIP Number 229050307
ISIN Number US2290503075
Employer ID 88-0313393
SIC Code 2834

Key Executives

Name Position
Jerrell W. Shelton Chairman, President and Chief Executive Officer
Robert S. Stefanovich MS Chief Financial Officer and Treasurer
Edward J. Zecchini Senior Vice President and Chief Digital and Technology Officer
Dr. Mark W. Sawicki Ph.D. Chief Scientific Officer
Thomas J. Heinzen Vice President of Corporate Development and Investor Relations
Tony Ippolito Vice President, General Counsel and Corporate Secretary
Kylie A. Crowe Vice President of Global Human Resources and Organizational Development
Bret Bollinger Vice President and Chief Innovation Officer
Phil Wilson Chief Operating Officer of Cryoport Systems, LLC

Latest SEC Filings

Date Type Title
Nov 22, 2024 144 Filing
Nov 20, 2024 144 Filing
Nov 19, 2024 144 Filing
Nov 18, 2024 144 Filing
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 7, 2024 10-Q Quarterly Report
Nov 7, 2024 8-K Current Report